# Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke

Study · id `cardio:ct-nct02388061` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02388061](<https://clinicaltrials.gov/study/NCT02388061>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02388061

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

## Technical summary

Registry record NCT02388061. Randomized; no masking; primary purpose treatment. Start 2015-03-23 (actual); primary completion 2017-10-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 202 participants (enrolled count; ClinicalTrials.gov record NCT02388061, source copy `cardio:ctgov-nct02388061-2018-03-30`, retrieved 2026-10-26)
- Started: 2015-03-23 (actual) (ClinicalTrials.gov record NCT02388061, source copy `cardio:ctgov-nct02388061-2018-03-30`, retrieved 2026-10-26)
- Primary completion: 2017-10-16 (actual) (ClinicalTrials.gov record NCT02388061, source copy `cardio:ctgov-nct02388061-2018-03-30`, retrieved 2026-10-26)
- Completion: 2018-02 (actual) (ClinicalTrials.gov record NCT02388061, source copy `cardio:ctgov-nct02388061-2018-03-30`, retrieved 2026-10-26)
- Countries: Australia; New Zealand (ClinicalTrials.gov record NCT02388061, source copy `cardio:ctgov-nct02388061-2018-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02388061-2018-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
- Acronym: EXTEND-IA TNK
- Condition: Ischemic Stroke
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Tissue Plasminogen Activator
- Lead sponsor: Neuroscience Trials Australia
- Lead sponsor class: OTHER
- Collaborator: The Florey Institute of Neuroscience and Mental Health
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention name matches this record: Alteplase (Activase) (`cardio:alteplase`)
- Registry lists this organization as the lead sponsor: Neuroscience Trials Australia (`cardio:org-neuroscience-trials-australia`)
- Registry lists this organization as a collaborator: The Florey Institute of Neuroscience and Mental Health (`cardio:org-the-florey-institute-of-neuroscience-and-mental-health`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study (`cardio:pubmed-28952914`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke (`cardio:pubmed-29694815`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f6acee7b1e0e141add12ee174f5c33b59026bf2604bc2d27a7168678b7c3047f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
